Ajanta Pharma Limited

NSE:AJANTPHARM.NS

3198.5 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Operating Activities:
Net Income 8,161.77,452.59,094.89,001.86,639.75,142.76,225.66,481.65,4744,560.13,130.61,767.9909.583565.664387.609298.143288.792193.725142.5293.986
Depreciation & Amortization 1,3541,3081,2531,160.9957.2720.8595.9612.1450.6516.4438.8341.7318.692247.485207.336141.98878.74287.44789.50792.24
Deferred Income Tax 0-1,565.2-2,828.5-2,395-1,960.1-1,230.8-1,393.4-1,347.4-1,477.6-1,525.6-789.6-332.300000000
Stock Based Compensation 54.92.230.24.26.713.414.53.112.14.900000000
Change In Working Capital -997.7665.2-2,003.9-2,087.5-1,231.6-903.2-2,591.4285.2-1,235.2-816.9-745.1384.8-570.458113.807215.652-279.62-325.297-156.578-95.427-307.779
Accounts Receivables -1,954.5-105.5-2,696.8311.3-2,683.8-144.3-1,692.4185.2-1,145.4-581.9-524.6-94.700000000
Inventory -123-223.7-256.6-2,714.5-589.3-853.3-1,389.7-64.5-455.5-36.3-78202.1-546.80565.04-157.326-111.197-219.36615.387-49.176-148.308
Accounts Payables 408.5969.1-480.2111.51,328.1-243722.4246.3365.100000000000
Other Working Capital 671.325.31,429.7204.2713.4337.4-1,201.7349.7-779.7-780.6-667.1182.7-23.65348.767372.978-168.423-105.931-171.965-46.251-159.471
Other Non Cash Items 3,944.355.110282.7158.311.64.134.948.959.287.3191.3107.59578.86140.564185.41148.57186.705116.84655.623
Operating Cash Flow 8,085.37,917.85,620.45,763.14,567.73,747.82,854.26,080.93,263.82,794.22,124.12,358.3765.4121,005.816951.161345.921190.808211.299253.446-65.93
Investing Activities:
Investments In Property Plant And Equipment -1,524.1-1,744.9-1,488.4-1,716.1-2,394.2-3,429.7-2,627.2-3,014.6-2,966-1,035.7-1,348.3-912.2-493.194-406.587-428.65-823.683-592.257-242.694-108.98-17.969
Acquisitions Net 133.8183.7183.817.154.96.31.1324.31,027.335.9000000000
Purchases Of Investments -20,799.7-16,668.6-10,628.7-7,424.1-2,780-2,746.4-2,326.8-3,594.4-469.3-966.3-658.4-142.9-0.0250000-1000
Sales Maturities Of Investments 22,573.912,761.510,916.56,461.52,763.23,924.52,357.12,687.91,330.8418.492.9046.23700001000.447
Other Investing Activites 267.9-127.7275.8-162.311217.3-8.312.711.6-1,027.3-0.12.41.7621.1571.994.310.8232.290.8450.431
Investing Cash Flow 383.9-5,596-741-2,823.9-2,244.1-2,228-2,604.1-3,908.4-2,092.9-1,583.6-1,878-1,052.7-445.22-405.43-426.66-819.373-591.434-240.404-108.135-17.091
Financing Activities:
Debt Repayment -0.6-4.9-2.3-440.2-97.3-341.8-5.1-745.6-193.6-581.1-36.3-1,29100000000
Common Stock Issued 014.4-2.3440.20-9.9000.10.10.1000000000
Common Stock Repurchased -3,891.9-14.4-2,855.9-1,354.10-1,00000350.3-60.25.9000000000
Dividends Paid -6,421.7-896.9-822.1-829-1,159.3-791.2-3-1,141.9-1,227.9-350.9-146.1-87.3-58.244-40.744-29.07-29.181-23.277-17.3640-0.002
Other Financing Activities -9.2-176.9-917.8-999.8-54.6668.31-180-114.6-59.8-24.9333.4-216.289-560.423-427.727525.666407.03453.762-106.23587.538
Financing Cash Flow -10,475.3-1,078.7-4,600.4-3,182.9-1,286.3-1,474.6-2-2,067.5-1,185.7-1,051.9-201.3-1,044.9-274.533-601.167-456.797496.485383.75736.398-106.23587.536
Other Information:
Effect Of Forex Changes On Cash 09.5-4.834.62.6-2.500000.10.10000000.0020.001
Net Change In Cash -1,998.81,243.1279-243.61,037.345.2248.1105-14.8158.744.9260.845.659-0.78167.70423.033-16.8697.29339.0784.516
Cash At End Of Period 1,307.73,306.72,054.11,779.91,988.9951.6906.4519.2530.1544.9386.2341.381.748147.605148.38680.68257.64974.51867.22528.147